Navigation Links
Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock
Date:8/6/2013

span> 55402, by telephone at (800) 747-3924 or by e-mail at prospectus@pjc.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more information on Vanda, please visit www.vandapharma.com.  

Cautionary Statement Regarding Forward-Looking Statements

This communication includes forward-looking statements regarding events, trends and business prospects, which may affect Vanda's future operating results and financial position. Such statements, including, but not limited to, those regarding statements about Vanda's expectations regarding its fundraising efforts, including the closing of the public offering and the underwriter's exercise of its over-allotment option, involve known and unknown risks that relate to Vanda's future events or future financial performance and the actual results could differ materially from those discussed in this communication. Risks and uncertainties that may cause Vanda's actual results to differ materially from those discussed in this communication can be found in the "Risk Factors" section of Vanda's Form 10-K, Forms 10-Q and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof, and Vanda assumes no responsibility to update or revise any forward-looking statements contained in this communication to reflect events, trends or circumstances
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
2. Vanda Pharmaceuticals Reports Second Quarter 2013 Results
3. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
4. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
5. Vanda Pharmaceuticals, Inc. Sued by Investor
6. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
7. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
8. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
9. Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
10. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
11. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... PITTSBURGH , May 26, 2015  Mylan ... company, today announced that Mylan CEO Heather Bresch ... Conference, Friday, May 29, 2015 at 9 a.m. ET.  ... webcast of the presentation via the investor relations section ... version will also be available following the live presentation ...
(Date:5/26/2015)... LOS ANGELES , May 26, 2015  Over ... showing the many health benefits that a sleeve gastrectomy, ... have for severely obese patients. More recently, a study ... Journal of Surgical Research , showed that obese patients ... improvements in their symptoms after successfully losing weight with ...
(Date:5/26/2015)... , May 26, 2015 ... business solutions, today announced the results of an ... perform day-to-day activities. 759 therapists, practice owners and ... a widespread industry need for technology and services ... to the survey findings, Clinicient published a free ...
Breaking Medicine Technology:Add Overactive Bladder Syndrome to the List of Conditions Shown to Be Improved by a Sleeve Gastrectomy 2Survey: Half of Physical Therapists Underbill For Their Services 2
... YORK, Feb. 9, 2011 Reportlinker.com announces that ... its catalogue: Cetuximab - Comprehensive ... Eliminate unnecessary risk with the ... Pipeline Developer is a regularly updated, professional patent ...
... 9, 2011 Reportlinker.com announces that a ... its catalogue: Global Physician ... Treatment 2011 http://www.reportlinker.com/p0377969/Global-Physician-Survey-on-Stents-Stent-Grafts-and-Vulnerable-Plaque-Treatment-2011.html ... responses of a comprehensive survey conducted of ...
Cached Medicine Technology:Reportlinker Adds Cetuximab - Comprehensive patent search 2Reportlinker Adds Cetuximab - Comprehensive patent search 3Reportlinker Adds Cetuximab - Comprehensive patent search 4Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011 2
(Date:5/26/2015)... 26, 2015 Neeta Pai was diagnosed ... and fainting spells, four of which landed her in ... arrest. , Though she still struggles with anemia, ... dedicate her time to increasing HHT awareness and garnering ... been awareness, we could have prevented all the heartbreak ...
(Date:5/26/2015)... ALEXANDRIA, VA (PRWEB) May 26, 2015 ... the experts at America’s 55 poison centers applaud the ... prevention of opioid addiction, according to Stephen T. Kaminski, ... Safe Prescribing of Controlled Substances Act, introduced by Senator ... would require prescribers of opioid pain medications and other ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Surging to ... one of the leading online health and wellness sites, ... to the online community. It has proven to ... to read articles, watch videos, ask questions and interact ... launch of the official Consumer Health Digest YouTube Channel ...
(Date:5/26/2015)... Irwin Gross, M.D., Accumen, Inc.’s ... Blood Management (PBM) initiative at Eastern Maine Medical Center ... more than 60 percent and improved patient outcomes over ... an article in the May 2015 edition of Transfusion, ... cell loss, less acute kidney injury and cut the ...
(Date:5/26/2015)... CO (PRWEB) May 26, 2015 It ... diverse community foundation in Colorado. On Wednesday, May 13, ... ushered in a new era of community-based giving with ... Titled “Our Future in the Making,” the event celebrated ... The Denver Foundation to mobilize resources for good. , ...
Breaking Medicine News(10 mins):Health News:Rochester Woman Brings Awareness to Genetic Disease 2Health News:American Association of Poison Control Centers Supports Legislative Initiatives Targeting the Responsible Prescription of Opioid Pain Medication 2Health News:American Association of Poison Control Centers Supports Legislative Initiatives Targeting the Responsible Prescription of Opioid Pain Medication 3Health News:Consumer Health Digest Official YouTube Channel: A Reliable Source of Health Information 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3
... also had raised cholesterol, so study suggests better screening ... -- While untreated hypertension in any child could lead ... of one chamber of the heart, a new study ... risk than all other racial groups. , While studying ...
... themselves from the swine flu virus, one of the best protections may ... general public during this crisis , ... New Port Richey, FL (PRWEB) ... spread of the swine flu virus/ H1N1, politicians, governments and citizens are ...
... severity of damage, longer recovery, study finds , , SATURDAY, May ... lower body appear to be more vulnerable to injury in ... , The study analyzed the weight and injuries of kids ... period. Sprains, such as to the ankle or leg, were ...
... Saunders & Schmieler, P.C. recently received the honor of listing in ... ... Silver Spring, MD (Lexis Nexis) May 2, 2009 -- ... the 2010 Martindale-Hubbell® Bar Register of Preeminent Lawyers™ guide. Fewer ...
... Cross Blue Shield of Michigan and Blue Care Network launched ... to find out information about their BCBSM and BCN health ... for BCBSM and bcbsm.com/chryslerbcn for Blue Care Network.BCBSM ... usual manner at this time. "We launched the web sites ...
... cancer that is resistant to standard therapy is the use ... in some settings, in many cases the therapies have had ... now been uncovered by a team of researchers, led by ... School of Medicine and Dentistry, London. , In the study, ...
Cached Medicine News:Health News:Black Youths With High BP May Face Elevated Heart Risks 2Health News:Cleanose Personal Air Filters Offer Added Protection From Inhaled Viruses/ Swine Flu/ H1N1 and Other Inhaled Dangers 2Health News:Obese Children More Likely to Suffer Lower Body Injuries 2Health News:Insurance Defense Law Firm Receives Recognition from Martindale-Hubbell 2
Indications For Usage:, ,Single use on tracheostomy patients who can breathe spontaneously. The product is intended to be replaced at least once every 24 hours....
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
Indications For Usage: , ,For use during pulmonary lung function testing...
Medicine Products: